Functional Genomics
Genome Editing
Assay Development
What We Do Best
Deep technical expertise across the full translational biology spectrum — from target identification through clinical biomarker readiness.
CRISPR Functional Genomics
Genome-wide and targeted CRISPR knockout, activation, and interference screens in primary and transformed cell lines using pooled and arrayed formats.
Perturb-seq for AI/ML
Large-scale single-cell CRISPR perturbation datasets (Perturb-seq) designed and executed to train foundation models and support AI-driven target discovery pipelines.
ddPCR & NGS Biomarkers
Digital PCR and next-generation sequencing-based biomarker assay development, qualification, and validation — ready for IND submissions and clinical trial monitoring.
IND-Enabling Assay Development
End-to-end clinical assay development — from concept through GLP-aligned validation — generating investor-grade data packages for IND filing and regulatory strategy.
CRISPR Target Validation
Rigorous genetic target validation using CRISPR perturbation approaches in disease-relevant cell models, supporting therapeutic hypothesis testing and prioritization.
Fractional Scientific Leadership
Part-time embedded scientific leadership — serving as Fractional Chief Translational Officer to seed and Series A biotechs that need expert guidance without full-time overhead.
Ready to accelerate your research and translational program?
From CRISPR screen design to IND-enabling assay development and validation — we bring the scientific depth your program needs without the full-time overhead.